Jeandel Pierre-Yves, Traissac Thalie, Rainfray Muriel, Bourdel-Marchasson Isabelle
Département de médecine interne et gériatrique, Centre Henri Choussat, Hôpital Xavier-Arnozan, avenue du Haut Lévêque, Pessac.
Presse Med. 2005 Apr 9;34(7):516-8. doi: 10.1016/s0755-4982(05)83962-4.
Lamotrigine is an antiepileptic agent used in a wide range of seizure disorders among the elderly. In rare cases, it can induce a drug hypersensitivity syndrome (DHS).
DHS due to lamotrigine was observed in two patients (85 and 91 years-old). The first case was characterized by febrile erythema with eosinophilia and the second by isolated fever. Lamotrigine was replaced by sodium valproate for one patient. Both patients had satisfactory outcomes after discontinuing lamotrigine.
Lamotrigine can induce DHS that is clinically and biologically similar to the DHS observed with standard antiepileptic drugs. It may involve concomitant or consecutive treatment with other antiepileptic agents, in particular, valproate acid, which decreases lamotrigine clearance. Potentially serious and even fatal, these adverse reactions are to be feared in a population with multiple comorbidities and can cause harmful diagnostic mistakes. They are especially fearsome in geriatric populations with high epilepsy rates.
拉莫三嗪是一种抗癫痫药物,用于治疗老年人群中的多种癫痫发作疾病。在罕见情况下,它可诱发药物超敏反应综合征(DHS)。
两名患者(分别为85岁和91岁)出现了由拉莫三嗪引起的DHS。第一例的特征为伴有嗜酸性粒细胞增多的发热性红斑,第二例为单纯发热。其中一名患者的拉莫三嗪被丙戊酸钠替代。两名患者停用拉莫三嗪后均取得了满意的疗效。
拉莫三嗪可诱发DHS,在临床和生物学方面与标准抗癫痫药物引起的DHS相似。它可能与其他抗癫痫药物联合使用或先后使用有关,尤其是丙戊酸,丙戊酸会降低拉莫三嗪的清除率。这些不良反应可能严重甚至致命,在患有多种合并症的人群中令人担忧,并且可能导致有害的诊断错误。在癫痫发病率高的老年人群中尤其令人恐惧。